RELEReleases

Meant Health Scales Telehealth Access to GLP-1 Prescriptions

Manassas-based digital health platform Meant Health is streamlining patient access to FDA-approved GLP-1 medications, including Ozempic. By connecting users directly with licensed clinicians, the company aims to simplify the evaluation process for those seeking medical weight management support and ongoing clinical oversight.

Bio & NewsSeptember 15, 2026232 reads0

The process begins with a digital intake questionnaire detailing a patient’s health history and current medications. A U.S.-licensed clinician then reviews these submissions to determine medical necessity on a case-by-case basis. While Ozempic holds FDA approval specifically for type 2 diabetes, clinicians may authorize its use for weight management at their professional discretion, an approach that remains a key component of the platform’s expansion.

Beyond the initial prescription, Meant Health integrates long-term care coaching into the patient experience. This structure is designed to move beyond a single consultation, providing consistent support as individuals navigate their specific health plans. Clinical oversight is facilitated through partnerships with entities like OpenLoop Health, ensuring that all medical evaluations and prescribing decisions remain under the authority of licensed practitioners rather than the technology platform itself.

Comments (0)

Leave a comment

No comments yet. Be the first!